Nippon India Nifty Pharma ETF
Fund DNA: what the numbers say
| Relative performance | Its 3-year return ranks 32 of 354 Index Funds ETFs funds (22.4% a year vs a category median of 7.9%). |
|---|---|
| Size | With ₹1,763 Cr of assets, it is number 109 of 731 Index Funds ETFs funds by size. |
Generated from this fund's data and compared with other funds in its category. Facts about the past, not a rating or a recommendation.
Returns vs benchmark and category
| Period | This fund | Benchmark | Category average | Rank in category |
|---|---|---|---|---|
| 1 year | 19.5% | 19.8% | -2.4% | 21 of 354 |
| 3 years | 22.4% | 22.7% | 11.4% | 32 of 354 |
| 5 years | 14.6% | 14.8% | 9.4% | 21 of 354 |
| Since launch | 12.9% | — | — | — |
Periods over one year are annualised (CAGR). Benchmark: Nifty Pharma TRI (as reported to AMFI). Category average is the average of funds in Index Funds ETFs.
NAV history
Consistency
Rolling returns need at least 3 years of NAV history, which this fund does not have yet in our data.
Risk
Sharpe and Sortino use a risk-free rate of 6.5% a year and weekly returns. Beta and alpha are measured against the average of funds in the same category. How we calculate these.
What ₹10,000 a month or ₹1 lakh would have become
Not enough NAV history yet.
Portfolio
Holdings, sector and market-cap split will appear here once this fund's monthly portfolio disclosure is loaded.
Fund details
| Fund house | Nippon India Mutual Fund |
| Category | Index Funds ETFs (Other) |
| Benchmark | Nifty Pharma TRI |
| Riskometer (fund / benchmark) | Very High / Very High |
| Launch date | 21 Jun 2021 |
| Minimum investment | ₹0 |
| Expense ratio | — |
| Exit load | See scheme documents |
| Fund manager | — |
| AMFI scheme code | — |
| ISIN (Growth) | — |
Similar funds in Index Funds ETFs
| Fund | AUM | 1Y | 3Y | 5Y | Compare |
|---|---|---|---|---|---|
| SBI Nifty 50 ETF | ₹2.06 L Cr | -11.1% | 7.5% | 6.5% | vs this fund |
| SBI BSE Sensex ETF | ₹1.19 L Cr | -12.0% | 6.3% | 5.8% | vs this fund |
| UTI Nifty 50 ETF | ₹71,275 Cr | -11.1% | 7.6% | 6.5% | vs this fund |
| Nippon India ETF Nifty 50 BeES | ₹67,650 Cr | -11.1% | 7.6% | 6.5% | vs this fund |
| UTI BSE Sensex ETF | ₹56,408 Cr | -11.9% | 6.3% | 5.8% | vs this fund |
| Nippon India ETF Gold BeES | ₹55,717 Cr | 16.5% | 31.0% | 22.9% | vs this fund |
Frequently asked questions
What is the NAV of Nippon India Nifty Pharma ETF?
What returns has Nippon India Nifty Pharma ETF given?
Is Nippon India Nifty Pharma ETF risky?
How does Nippon India Nifty Pharma ETF rank in its category?
This page is for information only and is not a recommendation to buy, sell or hold this scheme. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance may or may not be sustained in future. Figures are calculated from AMFI data and may differ slightly from the fund house's factsheet.